Overexpression of Transferrin Receptor and Ferritin Related to Clinical Symptoms and Destabilization of Human Carotid Plaques
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Accumulation of tissue iron has been implicated in development of atherosclerotic lesions mainly because of increased iron-catalyzed oxidative injury. However, it remains unknown whether cellular iron import and storage in human atheroma are related to human atheroma development. We found that transferrin receptor 1 (TfR1), a major iron importer, is highly expressed in foamy macrophages and some smooth muscle cells in intimal lesions of human carotid atheroma, mainly in cytoplasmic accumulation patterns. In 52 human carotid atherosclerotic lesions, TfR1 expression was positively correlated with macrophage infiltration, ectopic lysosomal cathepsin L, and ferritin expression. Highly expressed TfR1 and ferritin in CD68-positive macrophages were significantly associated with development and severity of human carotid plaques, smoking, and patient’s symptoms. The findings suggest that pathologic macrophage iron metabolism may contribute to vulnerability of human atheroma, established risk factors, and their clinical symptoms. The cytoplasmic overexpression of TfR1 may be the result of lysosomal dysfunction and ectopic accumulation of lysosomal cathepsin L caused by atheroma-relevant lipids in atherogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, it is well documented that arterial macrophages, typically identified by CD68 histochemistry on histologic sections within atherosclerotic lesions, contain larger amounts of FT than those outside plaques [129, 256].”
From “Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels (2017) · cites this paper as [129]
Citations
Cites
The ferritins: molecular properties, iron storage function and cellular regulation
Harrison, P. M., & Arosio, P. (1996) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(96)00022-9 · Cited by 2,667 · cited 1×
“However, haemin derived from hemoglobin degradation following erythrophagocytosis may be an important ferritin inducer in atherogenesis (32).”
BackgroundIntraplaque Hemorrhage and Progression of Coronary Atheroma
Kolodgie, F. D., Gold, H. K., Burke, A. P., Fowler, D. R., Kruth, H. S., Weber, D. K., Farb, A., Guerrero, L. J., Hayase, M., Kutys, R., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035655 · Cited by 1,486 · cited 1×
“Secondly, intraplaque hemorrhage, erythrophagocytosis, and apoptotic cell phagocytosis may result in accumulation of excessive cellular iron (5, 18) and influence TfR1 expression (19).”
BackgroundDaniels, T. R., Delgado, T., Rodriguez, J. A., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.010 · Cited by 634 · cited 1×
“There is substantial data that both ferritin and TfR1 can be degraded or internalized in lysosomes or endosomes (11, 12).”
BackgroundLocalization of Apoptotic Macrophages at the Site of Plaque Rupture in Sudden Coronary Death
Kolodgie, F. D., Narula, J., Burke, A. P., Haider, N., Farb, A., Hui-Liang, Y., Smialek, J., & Virmani, R. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64641-x · Cited by 366
Stadler, N., Lindner, R. A., & Davies, M. J. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000124892.90999.cb · Cited by 310
Lehr, H.-A., Mankoff, D. A., Corwin, D., Santeusanio, G., & Gown, A. M. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704501112 · Cited by 308
Release of iron from ferritin requires lysosomal activity
Kidane, T. Z., Sauble, E., & Linder, M. C. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00505.2005 · Cited by 263 · cited 3×
“Under certain conditions ferritin can even release redox-active iron and thus may also function as a prooxidant (12, 30, 31).”
BackgroundThe Transferrin Receptor: A Potential Molecular Imaging Marker for Human Cancer
Högemann-Savellano, D., Bos, E., Blondet, C., Sato, F., Abe, T., Josephson, L., Weissleder, R., Gaudet, J., Sgroi, D., Peters, P. J., et al. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80034-9 · Cited by 201 · cited 1×
“TfRs have been explored as molecular targets for imaging and treatment of rapid growth tumors (36, 37).”
BackgroundHistopathology of Carotid Atherosclerotic Disease
Virmani, R., Ladich, E. R., Burke, A. P., & Kolodgie, F. D. (2006) · Neurosurgery · doi:10.1227/01.neu.0000239895.00373.e4 · Cited by 184 · cited 1×
“It has been demonstrated that both the mechanisms and the imaging modalities of plaque instability in the carotid circulation may well reflect those in the coronary circulation (14, 15).”
BackgroundIron-Deficient Diet Reduces Atherosclerotic Lesions in ApoE-Deficient Mice
Lee, T.-S., Shiao, M.-S., Pan, C.-C., & Chau, L.-Y. (1999) · Circulation · doi:10.1161/01.cir.99.9.1222 · Cited by 179
Increased ferritin gene expression in atherosclerotic lesions.
Pang, J. H., Jiang, M. J., Chen, Y. L., Wang, F. W., Wang, D. L., Chu, S. H., & Chau, L. Y. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118661 · Cited by 162 · cited 1×
“Increased levels of iron and ferritin have been found mainly in CD68-positive macrophages of human atherosclerotic lesions and in the circulation of patients with atherosclerosis (2, 4, 5).”
BackgroundLysosomal destabilization during macrophage damage induced by cholesterol oxidation products
Yuan, X., Li, W., Brunk, U. T., Dalen, H., Chang, Y. H., & Sevanian, A. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00220-8 · Cited by 155
Self-citationMacrophage Iron, Hepcidin, and Atherosclerotic Plaque Stability
Sullivan, J. L. (2007) · Experimental Biology and Medicine · doi:10.3181/0703-mr-54 · Cited by 144 · cited 1×
“These findings are consistent with the proposal (38) that pathologic macrophage iron metabolism may contribute to the development and rupture of human atheroma and their clinical symptoms.”
ResultSelf-citationKitamoto, S., Sukhova, G. K., Sun, J., Yang, M., Libby, P., Love, V., Duramad, P., Sun, C., Zhang, Y., Yang, X., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.688523 · Cited by 130 · cited 1×
“Increased expression of cathepsin L has been demonstrated in human atherosclerotic lesions (24), and cathepsin L participates in atherosclerosis by degrading elastin and collagen and regulating blood-borne leukocyte transmigration and lesion progression in mice (25).”
BackgroundLi, W., Yuan, X. M., Olsson, A. G., & Brunk, U. T. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.2.177 · Cited by 122 · cited 2×
“Secondly, oxidized lipids under the influence of proinflammatory cytokines induce apoptosis or apoptosis-like cell death, in which the endo-lysosomal compartment and an iron-mediated pro-oxidant status may coordinately result in ectopic expression of both TfR1 and lysosomal cathepsins (6, 27).”
BackgroundSelf-citationIron in human atheroma and LDL oxidation by macrophages following erythrophagocytosis
Yuan, X., Li, W., OLSSON, A. G., & Brunk, U. T. (1996) · Atherosclerosis · doi:10.1016/0021-9150(96)05817-0 · Cited by 121
Self-citationApoptotic Death of Inflammatory Cells in Human Atheroma
Li, W., Dalen, H., Eaton, J. W., & Yuan, X.-M. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0701.092145 · Cited by 114 · cited 3×
“Thirdly, overexpression of TfR1 in human carotid atheroma may reflect the dysfunction of foam cell lysosomes induced by oxidized lipids as we showed previously (24, 28, 29) and as further established by a recent study (13).”
BackgroundResultSelf-citationAndreesen, R., Osterholz, J., Bodemann, H. H., Bross, K., Costabel, U., & L�hr, G. W. (1984) · Annals of Hematology · doi:10.1007/bf00319822 · Cited by 112 · cited 1×
“panied by high ferritin induction, suggesting that iron uptake and storage has a critical role in maturation of macrophages (17).”
BackgroundTsuji, Y., Miller, L. L., Miller, S. C., Torti, S. V., & Torti, F. M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)89638-0 · Cited by 103
Low Density Lipoprotein Undergoes Oxidation Within Lysosomes in Cells
Wen, Y., & Leake, D. S. (2007) · Circulation Research · doi:10.1161/circresaha.107.151704 · Cited by 103 · cited 2×
“The importance of lysosomes in iron-catalyzed low-density lipoprotein (LDL) oxidation in atherogenesis has been highlighted recently, although how lysosomes affect iron metabolism in human atherosclerotic lesions is still unknown (13).”
BackgroundResultIron Up-modulates the Expression of Transferrin Receptors during Monocyte-Macrophage Maturation
Testa, U., Petrini, M., Quaranta, M. T., Pelosi-Testa, E., Mastroberardino, G., Camagna, A., Boccoli, G., Sargiacomo, M., Isacchi, G., Cozzi, A., et al. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)51612-4 · Cited by 101 · cited 1×
“Secondly, intraplaque hemorrhage, erythrophagocytosis, and apoptotic cell phagocytosis may result in accumulation of excessive cellular iron (5, 18) and influence TfR1 expression (19).”
BackgroundMinqin, R., Rajendran, R., Pan, N., Kwong-Huat Tan, B., Ong, W.-Y., Watt, F., & Halliwell, B. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.01.008 · Cited by 100
The iron hypothesis of atherosclerosis and its clinical impact
Yuan, X., & Li, W. (2003) · Annals of Medicine · doi:10.1080/07853890310016342 · Cited by 93 · cited 2×
“Increased levels of iron and ferritin have been found mainly in CD68-positive macrophages of human atherosclerotic lesions and in the circulation of patients with atherosclerosis (2, 4, 5).”
BackgroundSelf-citationSeiser, C., Teixeira, S., & Kühn, L. C. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38621-1 · Cited by 92
Gamma-interferon modulates human monocyte/macrophage transferrin receptor expression
Taetle, R., & Honeysett, J. (1988) · Blood · doi:10.1182/blood.v71.6.1590.1590 · Cited by 75
The toxicity to macrophages of oxidized low-density lipoprotein is mediated through lysosomal damage
Yuan, X., Li, W., OLSSON, A. G., & Brunk, U. T. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00094-4 · Cited by 69 · cited 1×
“Thirdly, overexpression of TfR1 in human carotid atheroma may reflect the dysfunction of foam cell lysosomes induced by oxidized lipids as we showed previously (24, 28, 29) and as further established by a recent study (13).”
ResultSelf-citationChen, L., Xiong, S., She, H., Lin, S. W., Wang, J., & Tsukamoto, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m609273200 · Cited by 64 · cited 1×
“Some epidemiologic and many experimental studies suggest that development of atherosclerosis may be associated with the amount of iron storage in the human body (1, 2), which may lead to iron-driven oxidative stress and signaling in atherogenesis (3).”
BackgroundLapenna, D., Pierdomenico, S. D., Ciofani, G., Ucchino, S., Neri, M., Giamberardino, M. A., & CUCCURULLO, F. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.11.014 · Cited by 63
Yuan, X. M. (1999) · Free Radical Research · doi:10.1080/10715769900300241 · Cited by 59 · cited 2×
“Increased levels of iron and ferritin have been found mainly in CD68-positive macrophages of human atherosclerotic lesions and in the circulation of patients with atherosclerosis (2, 4, 5).”
BackgroundSelf-citationIron and peripheral arterial disease: revisiting the iron hypothesis in a different light
Ramakrishna, G., Rooke, T. W., & Cooper, L. T. (2003) · Vascular Medicine · doi:10.1191/1358863x03vm493ra · Cited by 54 · cited 1×
“Some epidemiologic and many experimental studies suggest that development of atherosclerosis may be associated with the amount of iron storage in the human body (1, 2), which may lead to iron-driven oxidative stress and signaling in atherogenesis (3).”
BackgroundHallerstam, S., Larsson, P. T., Zuber, E., & Rosfors, S. (2004) · Angiology · doi:10.1177/000331970405500307 · Cited by 43 · cited 1×
“It has been demonstrated that both the mechanisms and the imaging modalities of plaque instability in the carotid circulation may well reflect those in the coronary circulation (14, 15).”
BackgroundLi, W., Hellsten, A., Xu, L.-H., Zhuang, D., Jansson, K., Brunk, U. T., & Yuan, X. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.05.006 · Cited by 43
Self-citationDietary Iron Restriction Increases Plaque Stability in Apolipoprotein-E-Deficient Mice
Lee, H., Chiu, L.-L., Lee, T., Tsai, H.-L., & Chau, L. (2003) · Journal of Biomedical Science · doi:10.1007/bf02256112 · Cited by 37
Lepelletier, Y., Camara-Clayette, V., Jin, H., Hermant, A., Coulon, S., Dussiot, M., Arcos-Fajardo, M., Baude, C., Canionni, D., Delarue, R., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1962 · Cited by 37 · cited 1×
“TfRs have been explored as molecular targets for imaging and treatment of rapid growth tumors (36, 37).”
BackgroundSureda, A., Hebling, U., Pons, A., & Mueller, S. (2005) · Free Radical Research · doi:10.1080/10715760500164045 · Cited by 29 · cited 2×
“Extracellular H2O2 but not superoxide determines the compartment-specific activation of transferrin receptor by IRP1 (23).”
BackgroundAscorbate-mediated Iron Release from Ferritin in the Presence of Alloxan
Sakurai, K., Nabeyama, A., & Fujimoto, Y. (2006) · BioMetals · doi:10.1007/s10534-005-1300-x · Cited by 22 · cited 1×
“Under certain conditions ferritin can even release redox-active iron and thus may also function as a prooxidant (12, 30, 31).”
BackgroundGravitas, Severitas, Veritas, Virtus
Apuzzo, M. L. J. M. D. (2006) · Neurosurgery · doi:10.1227/01.neu.0000309836.57544.b0 · Cited by 20
Iron release analyses from ferritin by visible light irradiation
Ohishi, K., Zhang, X. M., Moriwaki, S., Hiramitsu, T., & Matsugo, S. (2005) · Free Radical Research · doi:10.1080/10715760500177807 · Cited by 16 · cited 1×
“Under certain conditions ferritin can even release redox-active iron and thus may also function as a prooxidant (12, 30, 31).”
BackgroundGravitas, Severitas, Veritas, Virtus
&NA; (2006) · Neurosurgery · doi:10.1227/00006123-200608000-00001 · Cited by 8
JR, W., & JR, V. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00710.x · Cited by 4 · cited 1×
“In murine macrophages, major histocompatibility complex II (MHC II)-peptide loading occurs in TfRpositive endosomes; MHC II-fluoresceinated complexes were only observed in TfR-positive organelles (26).”
Background
Cited by
Targeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352
Ferroptosis: the potential value target in atherosclerosis
Ouyang, S., You, J., Zhi, C., Li, P., Lin, X., Tan, X., Ma, W., Li, L., & Xie, W. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04054-3 · Cited by 199
“Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels
Nairz, M., Theurl, I., Swirski, F. K., & Weiss, G. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1944-8 · Cited by 178
Iron in arterial plaque: A modifiable risk factor for atherosclerosis
Sullivan, J. L. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.06.005 · Cited by 176
“Nearly three decades ago, it was suggested that a state of sustained iron depletion or mild iron de fi ciency exert a primary protective action against ischemic heart disease [1 – 8].”
Self-citationAutophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
Lin, L., Zhang, M.-X., Zhang, L., Zhang, D., Li, C., & Li, Y.-L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809955 · Cited by 164
“TFR1 promoted iron absorption and ferritin synthesis, and was found to accumulate significantly in the nuclear region of many foam cells, contributing to the development and rupture of atherosclerotic plaques (Li et al., 2008).”
Background
Metadata
- Authors
- Li, W., Xu, L.-H., Forssell, C., Sullivan, J. L., & Yuan, X.-M.
- Affiliations
- Linköping University (SE)
- Division of Pharmacology; Division of Experimental Pathology, Department of Clinical and Experimental Medicine; Division of Vascular Surgery, Department of Medicine and Health Sciences, Faculty of Health Sciences, Linköping University, Linköping, SE-58185 Sweden; and Burnett College of Biomedical Sciences, University of Central Florida, Orlando, Florida 32816
- Venue
- Experimental Biology and Medicine
- Publisher
- Frontiers Media SA
- Published
- 2008-07
- Volume
- 233
- Issue
- 7
- Pages
- 818-826
- ISSN
- 0071-3384 (ISSN-L)
- 1535-3702
- 1535-3699
- OpenAlex
- W2147372363
- Cited by
- 69
- References
- 39
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 7 · 2023: 9 · 2022: 7 · 2021: 4 · 2020: 2 · 2019: 4 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 1 · 2014: 3 · 2013: 3 · 2012: 5
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Experimental Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Journal of International Crisis and Risk Communication Research (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- transferrin receptor 1, ferritin, carotid atherosclerosis, foam cells, cathepsin L, lysosomal dysfunction, smooth muscle cells, smoking, clinical symptoms
- MeSH terms
- CD68 Molecule, Aged, Aged, 80 and over, Cathepsins, Cysteine Endopeptidases, Female, Ferritins, Gene Expression Regulation, Humans, Iron, Lysosomes, Macrophages, Male, Middle Aged, Muscle, Smooth, Vascular, Receptors, Transferrin, Severity of Illness Index, Antigens, Differentiation, Myelomonocytic, Antigens, CD, Carotid Stenosis, Atherosclerosis, Cathepsin L
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.